NOT-DK-25-005: Notice of Change to Application Due Date and Clarification of Application Types Allowed for RFA-DK-25-024 "Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)"

Notice of Change to Application Due Date and Clarification of Application Types Allowed for RFA-DK-25-024 "Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)"

Notice Number:

NOT-DK-25-005

Key Dates

Release Date:

November 7, 2024

Related Announcements

August 8, 2024 -Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional). See NOFO RFA-DK-25-024.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice of Change is to inform the community that RFA-DK-25-024 "Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)" has been modified to extend the due date and correct the Application Types Allowed.

Key Dates currently listed as:

Key Dates

Open Date (Earliest Submission Date)

October 21, 2024

Letter of Intent Due Date(s)

October 21, 2024

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS - New/Renewal/Resubmission/Revision, as allowed	Scientific Merit Review	Advisory Council Review	Earliest Start Date
Not Applicable	Not Applicable	November 21, 2024	March 2025	May 2025	July 2025

Expiration Date

November 22, 2024

Key dates modified to read (in Bold/Italics)

Key Dates

Open Date (Earliest Submission Date)

November 9, 2024

Letter of Intent Due Date(s)

November 9, 2024

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS - New/Renewal/Resubmission/Revision, as allowed	Scientific Merit Review	Advisory Council Review	Earliest Start Date
Not Applicable	Not Applicable	December 9, 2024	March 2025	May 2025	July 2025

Expiration Date

December 10, 2024

Section II. Award Information currently reads:

Section II. Award Information

Application Types Allowed

New
Resubmission - applications are only allowed from RFA-DK-20-022.

Section II. Award Information modified as shown in bold/italics as:

Section II. Award Information

Application Types Allowed

New
Resubmission - applications are only allowed from RFA-DK-22-039.

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Peter J. Perrin, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-3759
Email: [email protected]